Does PALIVIZUMAB Cause Off label use? 359 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 359 reports of Off label use have been filed in association with PALIVIZUMAB (Synagis). This represents 3.1% of all adverse event reports for PALIVIZUMAB.
359
Reports of Off label use with PALIVIZUMAB
3.1%
of all PALIVIZUMAB reports
26
Deaths
166
Hospitalizations
How Dangerous Is Off label use From PALIVIZUMAB?
Of the 359 reports, 26 (7.2%) resulted in death, 166 (46.2%) required hospitalization, and 8 (2.2%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALIVIZUMAB. However, 359 reports have been filed with the FAERS database.
What Other Side Effects Does PALIVIZUMAB Cause?
Respiratory syncytial virus infection (1,692)
Pyrexia (1,055)
Death (856)
Bronchiolitis (724)
Cough (665)
Pneumonia (657)
Dyspnoea (466)
Nasopharyngitis (462)
Vomiting (445)
Influenza (398)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which PALIVIZUMAB Alternatives Have Lower Off label use Risk?
PALIVIZUMAB vs PALONOSETRON
PALIVIZUMAB vs PAMIDRONATE
PALIVIZUMAB vs PAMIDRONIC ACID
PALIVIZUMAB vs PANCRELIPASE
PALIVIZUMAB vs PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE